Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,162 | -16,137 | -15,074 | N/A | N/A |
| Depreciation Amortization | 540 | 753 | 593 | N/A | N/A |
| Accounts receivable | -508 | -278 | 153 | N/A | N/A |
| Other Working Capital | 629 | -5,045 | -1,091 | N/A | N/A |
| Other Operating Activity | 5,085 | 2,728 | 5,819 | 0 | 0 |
| Operating Cash Flow | $-11,416 | $-17,979 | $-9,600 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -77 | -697 | -385 | N/A | N/A |
| Purchase Of Investment | -598 | -11,122 | -15,804 | N/A | N/A |
| Sale Of Investment | 2,650 | 19,325 | 8,651 | N/A | N/A |
| Investing Cash Flow | $1,975 | $7,506 | $-7,538 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,000 | N/A | 5,600 | N/A | N/A |
| Debt Repayment | -1,200 | -1,256 | -722 | N/A | N/A |
| Common Stock Issued | 43 | 20 | 29 | N/A | N/A |
| Other Financing Activity | -1,320 | 0 | 31,069 | 0 | 0 |
| Financing Cash Flow | $3,523 | $-1,236 | $35,976 | $N/A | $N/A |
| Beginning Cash Position | 8,343 | 20,052 | 1,214 | N/A | N/A |
| End Cash Position | 2,425 | 8,343 | 20,052 | N/A | N/A |
| Net Cash Flow | $-5,918 | $-11,709 | $18,838 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,416 | -17,979 | -9,600 | N/A | N/A |
| Capital Expenditure | -77 | -697 | -385 | N/A | N/A |
| Free Cash Flow | -11,493 | -18,676 | -9,985 | 0 | 0 |